Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes

NCT02397421 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Diabetes

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

University of Dundee

Collaborators

[object Object]